TRANSDERMAL OR TRANSMUCOSAL PHARMACEUTICAL FORMS WITH A NICOTINE-CONTAINING ACTIVE SUBSTANCE FOR SMOKING Cessation

• 1. 用于治疗钙化的含阿司匹林的透皮吸收药物组合物 [P] . 中国专利： CN100342913C . 2007.10.17
• 2. 用于治疗钙化的含阿司匹林的透皮吸收药物组合物 [P] . 中国专利： CN1610558A . 2005-04-27
• 3. Transdermal or transmucosal administration forms with a nicotine-containing active ingredient combination for smoking cessation [P] . DK1274405T3 . 2004-10-11

  机译： 经皮或透粘膜给药形式与含尼古丁的活性成分联合用于戒烟

• 4. "TRANSDERMAL OR TRANSMUCOSAL DOSAGE FORMS WITH A NICOTINE-CONTAINING ACTIVE SUBSTANCE COMBINATION FOR SMOKER DISINTOXICATION" [P] . IN2002DN00977A . 2017-04-07

  机译： “含烟碱的活性物质组合的烟尘脱毒的经皮或经皮剂量形式”

• 5. TRANSDERMAL OR TRANSMUCOSAL DOSAGE FORMS WITH A NICOTINE-CONTAINING ACTIVE SUBSTANCE COMBINATION FOR SMOKER DISINTOXICATION [P] . 韩国专利： KR100601901B1 . 2006-07-14

  机译： 含烟碱的活性物质组合的烟尘脱毒的透皮或经皮剂量形式

• 1. Nicotine transdermal patch for smoking cessation using combination of hydrophilic and hydrophobic polymers as matrix film formers [J] . Danaipat Sukphong, Thesisanin Rojanaratha, Marut Srivarnitpoom, 亚洲药物制剂科学(英文) . 2016,第001期
• 2. Improving the bioavailability of pharmacologically active substances in pharmaceutical and cosmetic formulations [J] . Joachim Storsberg, Marcel W.Laughton, Martin Geyer, 亚洲药物制剂科学(英文) . 2016,第001期
• 3. Impacts of Preoperative Smoking and Smoking Cessation Time on Preoperative Peripheral Blood Inflammatory Indexes and Postoperative Hospitalization Outcome in Male Patients with Lung Cancer and Surgery Treatment [J] . Longming Xu, Shuiping Dai, Yunxia Zuo 中国医学科学杂志（英文版） . 2020,第002期
• 4. Combined Transdermal Administration of Nicotine and Bupropion for Smoking Cessation Therapy [C] . Serena Cella, Sara Nicoli, Patrizia Santi Annual meeting exposition of the Controlled Release Society . 2005
• 5. Effectiveness of one smoking cessation education session on changing client attitudes about their smoking behaviors in adults seeking treatment for substance addictions [D] . Wirzman, Jillian L. 2009
• 6. Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation [O] . Valentina Buda, Minodora Andor, Adriana Ledeti, 2017
• 7. A Stability-Indicating Ultra-Performance Liquid Chromatographic Method for Estimation of Related Substances and Degradants in Paliperidone Active Pharmaceutical Ingredient and its Pharmaceutical Dosage Forms [O] . K. H. Bindu, I. U. Reddy, Y. Anjaneyulu, 2012
• 8. Smoking Cessation: Clinical Practice Guideline No. 18; Smoking Cessation:Information Specialists, Quick Reference Guide for Smoking Cessation Specialists No. 18; Helping Smokers Quit: A Guide for Primary Care Clinicians; You Can Quit Smoking: Consumer Ver [R] . 1996

• 1. Simultaneous Determination of N-Acetyl Cysteine and Taurine by HPTLC Method in Active Pharmaceutical Ingredient and Pharmaceutical Dosage Form [J] . A. R. Magesh ,Magharla Dasaratha Dhanaraju . 美国分析化学（英文） . 2017,第11期
• 2. Geographical Analysis of Smoking in Leeds: A GIS-Based Location-Allocation Technique for the Optimal Location of Smoking Cessation Services [J] . Mildred Oiza Ajebon ,Monday Ohi Asikhia . 地理信息系统（英文） . 2013,第3期
• 3. 脂质体电动色谱用于评价药物透皮吸收 [C] . 王永军 ,刘洪卓 ,孙进 . 2008中国药学会学术年会暨第八届中国药师周 . 2008
• 4. 纳米囊泡结合物理透皮技术用于药物经皮给药的研究 [A] . 郑静南 . 2007